MIAMI--(BUSINESS WIRE)--IVAX Diagnostics, Inc. (NYSE Amex:IVD), a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2011. Kevin D. Clark, Chief Executive Officer, Chief Operating Officer and President of IVAX Diagnostics, said, “We are pleased to report our financial performance for the second quarter of 2011. Our operating expenses and operating loss were lower in the second quarter of 2011 compared to the corresponding period in 2010. Our revenues for the second quarter of 2011 were approximately at the same level as the second quarter of 2010. Our cash and cash equivalents balance improved from $1.8 million as of December 31, 2010 to $5.2 million as of June 30, 2011.
